HRT Financial’s MiMedx Group MDXG Stock Holding History

HRT Financial’s Portfolio MDXG Stock Details MDXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.17M	Buy	564,048 +224,034	+66%	+$818K	﹤0.01%	1697
2026 Q1	$1.34M	Buy	340,014 +43,363	+15%	+$218K	﹤0.01%	1875
2025 Q4	$2.01M	Buy	296,651 +147,554	+99%	+$1.03M	0.01%	1305
2025 Q3	$1.04M	Buy	+149,097	New	+$1.04M	﹤0.01%	1499
2024 Q1	–	Sell	-16,169	Closed	-$141K	–	2778
2023 Q4	$141K	Buy	+16,169	New	+$118K	﹤0.01%	1847
2023 Q3	–	Sell	-32,706	Closed	-$216K	–	2814
2023 Q2	$216K	Buy	+32,706	New	+$167K	﹤0.01%	1807
2022 Q2	–	Sell	-28,152	Closed	-$132K	–	3383
2022 Q1	$132K	Buy	28,152 +14,674	+109%	+$71.8K	﹤0.01%	2598
2021 Q4	$81K	Sell	13,478 -11,432	-46%	-$79.4K	﹤0.01%	2793
2021 Q3	$150K	Buy	+24,910	New	+$281K	﹤0.01%	2781
2021 Q2	–	Sell	-28,220	Closed	-$290K	–	3254
2021 Q1	$290K	Buy	+28,220	New	+$273K	﹤0.01%	2120
2015 Q3	–	Sell	-13,981	Closed	-$162K	–	150
2015 Q2	$162K	Buy	+13,981	New	+$144K	0.08%	128

Other funds holding MDXG

EWM

Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Trigran Investments Northbrook, Illinois $545M AUM 56.2% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

HRT Financial's MDXG Position: Q2 2026 in Review

HRT Financial increased its MiMedx Group (MDXG) stake by 66% in Q2 2026, buying an estimated $818K and bringing the position to 564,048 shares worth $2.17M. The position accounts for ﹤0.01% of the portfolio, ranked #1697.

HRT Financial first reported a position in MDXG in Q2 2015 and has held it in 11 quarters since. 227 funds tracked by Wall St. Rank hold MDXG as of Q2 2026.

HRT Financial held 564,048 shares of MiMedx Group worth $2.17M as of Q2 2026.
HRT Financial bought 224,034 MiMedx Group shares in Q2 2026, an estimated $818K.
MiMedx Group made up ﹤0.01% of HRT Financial's portfolio in Q2 2026, its #1697 holding.
HRT Financial first reported a position in MiMedx Group in Q2 2015 and has held it in 11 quarters since.
227 funds tracked by Wall St. Rank held MiMedx Group as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.